MyAverix Finance
US · Healthcare
Intensity Therapeutics, Inc. Common stock (INTS)
Biotechnology
Intensity Therapeutics, Inc. Common stock (INTS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for INTS
Intensity Therapeutics, Inc. Common stock (INTS) — FAQ
What is INTS's P/E ratio?
The price-to-earnings (P/E) ratio for Intensity Therapeutics, Inc. Common stock (INTS) is 25.00 (data as of 2026-05-23).
Does Intensity Therapeutics, Inc. Common stock pay a dividend?
Dividend yield is not available in the current snapshot for Intensity Therapeutics, Inc. Common stock (INTS). Check the MyAverix Finance app for the latest dividend data.
What sector is Intensity Therapeutics, Inc. Common stock in?
Intensity Therapeutics, Inc. Common stock (INTS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is INTS listed on?
INTS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.